Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 30251-30300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06235281
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
EARLY_PHASE1Recruiting
20 participants
Started: Jan 18, 2024 · Completed: Sep 1, 2029
1 condition2 sponsors1 location
NCT06139458
Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
NARecruiting
190 participants
Started: Jan 18, 2024 · Completed: May 31, 2027
2 conditions1 sponsor2 locations
NCT06387004
Radiation-Related Dysphagia Development Prediction Using a Two-Step Ultrasonographic Model (R-2D-2)
N/ARecruiting
112 participants
Started: Jan 18, 2024 · Completed: Feb 18, 2026
1 condition1 sponsor1 location
NCT06099353
Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting
NARecruiting
1,500 participants
Started: Jan 18, 2024 · Completed: Oct 30, 2024
1 condition3 sponsors1 location
NCT06100770
Aveir AR Coverage With Evidence Development (CED) Study
N/ARecruiting
586 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2031
3 conditions1 sponsor1 location
NCT05547594
Prehabilitation in Patients With Cancer and Type 2 Diabetes
NARecruiting
60 participants
Started: Jan 18, 2024 · Completed: Apr 30, 2025
2 conditions1 sponsor2 locations
NCT06224712
Arogya Sangama: 3 Way Partnership of People, Providers, and Panchayat for Health
NARecruiting
4,160 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2026
3 conditions2 sponsors2 locations
NCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors
PHASE1Recruiting
71 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2027
6 conditions2 sponsors6 locations
NCT06357598
Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer
PHASE4Recruiting
30 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06041334
Evaluation of MuLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
NARecruiting
50 participants
Started: Jan 18, 2024 · Completed: Jan 18, 2027
1 condition2 sponsors1 location
NCT06339879
Health Effects of Grain Foods in Adults
NARecruiting
120 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06162221
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
PHASE1/PHASE2Recruiting
616 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2028
5 conditions1 sponsor65 locations
NCT06043531
Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients
NARecruiting
30 participants
Started: Jan 18, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06018337
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
PHASE3Recruiting
532 participants
Started: Jan 18, 2024 · Completed: Jul 31, 2028
1 condition2 sponsors253 locations
NCT05788666
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
NARecruiting
150 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05903859
Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)
PHASE3Recruiting
90 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05458323
Cognitive Level Enhancement Through Vision Exams and Refraction
NARecruiting
760 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2028
1 condition8 sponsors1 location
NCT06369818
Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support
N/ARecruiting
50 participants
Started: Jan 18, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06202820
CV CARE: CardioVascular Care in PC Patients
NARecruiting
180 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05996835
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
PHASE2Recruiting
320 participants
Started: Jan 18, 2024 · Completed: Feb 20, 2026
1 condition1 sponsor118 locations
NCT06296849
Dyadic Financial Incentive Treatments for Dual Smoker Couples
NARecruiting
900 participants
Started: Jan 18, 2024 · Completed: May 31, 2028
1 condition3 sponsors1 location
NCT06210100
aiTBS for NSSI and Suicide in Adolescent Depression
NARecruiting
60 participants
Started: Jan 18, 2024 · Completed: Feb 1, 2025
3 conditions1 sponsor2 locations
NCT06059963
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
N/ARecruiting
15,000 participants
Started: Jan 18, 2024 · Completed: Mar 1, 2026
2 conditions4 sponsors1 location
NCT06206824
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
PHASE1Recruiting
120 participants
Started: Jan 18, 2024 · Completed: Jul 31, 2025
3 conditions4 sponsors1 location
NCT05763043
Monoferric for Prenatal Iron Deficiency
EARLY_PHASE1Recruiting
80 participants
Started: Jan 18, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06183671
JX09 SAD/MAD in Healthy Participants
PHASE1Recruiting
92 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06317129
Clinical Feasibility Study of the BariTon™ System in Obese Patients
NARecruiting
10 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06342336
HS-IT101 Injection in the Treatment of Advanced Solid Tumors
PHASE1Recruiting
44 participants
Started: Jan 18, 2024 · Completed: Mar 31, 2028
1 condition4 sponsors1 location
NCT06151743
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma
PHASE2Recruiting
32 participants
Started: Jan 18, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06227689
Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China
NARecruiting
1,800 participants
Started: Jan 18, 2024 · Completed: Jul 31, 2024
1 condition2 sponsors2 locations
NCT06218589
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
NARecruiting
200 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2026
2 conditions3 sponsors2 locations
NCT06208631
Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis
NARecruiting
31 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06244758
Finerenone and Renal Oxidative Stress
PHASE3Recruiting
75 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06081049
The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)
PHASE2Recruiting
152 participants
Started: Jan 18, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06130553
A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
234 participants
Started: Jan 18, 2024 · Completed: Feb 26, 2026
1 condition1 sponsor20 locations
NCT06225583
Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers
N/ARecruiting
40 participants
Started: Jan 17, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05917145
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PHASE1Recruiting
94 participants
Started: Jan 17, 2024 · Completed: Feb 28, 2029
1 condition1 sponsor1 location
NCT06263556
Effectiveness of TTNS in MS Patients With Lower Urinary Track Symptoms
NARecruiting
64 participants
Started: Jan 17, 2024 · Completed: Dec 5, 2024
2 conditions1 sponsor1 location
NCT06206265
Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
PHASE2Recruiting
14 participants
Started: Jan 17, 2024 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT06244368
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
PHASE2Recruiting
115 participants
Started: Jan 17, 2024 · Completed: Dec 30, 2027
2 conditions19 sponsors1 location
NCT06044740
Sevoflurane's Effect on Neurocognition Study
EARLY_PHASE1Recruiting
60 participants
Started: Jan 17, 2024 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06144944
Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer
PHASE3Recruiting
160 participants
Started: Jan 17, 2024 · Completed: Dec 31, 2031
4 conditions2 sponsors1 location
NCT06209099
Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
NARecruiting
96 participants
Started: Jan 17, 2024 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05960019
Blood Glucose Control Using African Traditional Fermented Foods
NARecruiting
252 participants
Started: Jan 17, 2024 · Completed: Dec 17, 2024
1 condition3 sponsors2 locations
NCT06426199
Chitosan-Hyaluronate Gel Mixture Vs Hyaluronic for Internal Derangement
PHASE4Recruiting
20 participants
Started: Jan 17, 2024 · Completed: Jul 1, 2024
1 condition3 sponsors1 location
NCT06193499
A Study on the Effect of High-concentrated Platelet Rich Plasma (PRP) on Osteoarthritis in the Thumb Base.
NARecruiting
90 participants
Started: Jan 17, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06136767
Registry for Systemic Eczema Treatments
N/ARecruiting
400 participants
Started: Jan 17, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06350695
The ROle of Compression StocKings in Heart Failure Patients
NARecruiting
50 participants
Started: Jan 17, 2024 · Completed: Jan 1, 2026
4 conditions3 sponsors1 location
NCT06429969
Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.
N/ARecruiting
450 participants
Started: Jan 17, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06008197
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
PHASE3Recruiting
5,200 participants
Started: Jan 17, 2024 · Completed: Apr 30, 2026
2 conditions3 sponsors4 locations